Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Zhang, F. [1 ]
Dong, N. [1 ]
Torres, S. [1 ]
Calabuig Farinas, S. [2 ,3 ,4 ]
Sirera Perez, R. [5 ]
Mosqueda, M. [1 ]
Escorihuela, E. [6 ]
Jantus-Lewintre, E. [7 ,8 ]
Camps, C. [3 ,9 ,10 ]
机构：
[1] Fdn Invest Hosp Gen Univ Valencia, Mol Oncol, Valencia, Spain
[2] Fdn Invest Hosp Gen Univ Valencia, Mol Oncol Lab, Mol Oncol, Valencia, Spain
[3] Ctr Invest Biomed Red Canc CIBEROnc, Madrid, Spain
[4] Univ Valencia, Dept Pathol, Valencia, Spain
[5] Univ Politecn Valencia CIBERONC, Dept Biotechnol, Valencia, Spain
[6] Fdn Invest Hosp Gen Univ Valencia CIBERONC, Mol Oncol, Valencia, Spain
[7] Fdn Invest Hosp Gen Univ Valencia, Mol Oncol Lab, Valencia, Spain
[8] Univ Politecn Valencia, Dept Biotechnol, Valencia, Spain
[9] Hosp Gen Univ Valencia, Dept Med Oncol, Med Oncol, Valencia, Spain
[10] Univ Valencia, Dept Med, Valencia, Spain
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1865P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Characterization of cancer stem cell and immune microenvironment interactions in non-small cell lung cancer (NSCLC)
    Torres, S.
    Sirera, R.
    Aguilar, C.
    Calabuig Farinas, S.
    Mosqueda, M.
    Herreros-Pomares, A.
    Escorihuela, E.
    Garcia del Olmo, E.
    Jantus-Lewintre, E.
    Camps Herrero, C.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
    Zhang, W.
    Yuan, X.
    Wang, X.
    Huang, S.
    Tu, J.
    Liu, F.
    Li, J.
    Li, J.
    Chen, Y.
    Chu, Q.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S132 - S132
  • [3] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    [J]. DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [4] The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer
    Luo, Lumeng
    Liu, Peiyi
    Zhao, Kuaile
    Zhao, Weixin
    Zhang, Xiaofei
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [6] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    [J]. JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [7] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [8] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    [J]. LUNG CANCER, 2001, 34 : S25 - S29
  • [9] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    [J]. INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [10] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345